OMER Q2 2018 Earnings — Omeros Corporation Revenue & Financial Results | Market Cap Arena

OMEROmeros Corporation

$821M

Q2 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-90.4% YoY

Gross Profit

$2M93.0% margin

Operating Income

-$31M-1850.0% margin

Net Income

-$34M-2036.0% margin

EPS (Diluted)

$-0.70

QoQ Revenue Growth

+4.2%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$31M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$106M

Total Liabilities

$163M

Stockholders' Equity

-$56M

Cash & Equivalents

$3M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$17M	-90.4%
Gross Profit	$2M	$17M	-90.9%
Operating Income	-$31M	-$12M	-156.4%
Net Income	-$34M	-$14M	-134.7%